Welcome to MS Views and News blog

MS Views and News, empowers those affected by Multiple Sclerosis (MS) with educational information, resources and services. Please scroll downward to find articles or videos of interest, then click to open the document or video.

Categories

Latest Blog Posts

December 14, 2023

Exercise Improves Physical Capacity, Cognition, Quality of Life and Promotes Neurotrophic Factors in Patients with Multiple Sclerosis – PubMed

  • Complementary & Alternative therapies and devices for Multiple Sclerosis (MS)
    /
 December 2023 Abstract Introduction: We aimed to determine the effect of regular exercise on aerobic capacity, strength values, and plasma levels…
Complementary & Alternative therapies and devices for Multiple Sclerosis (MS)

December 14, 2023

Pediatric Onset Multiple Sclerosis and Obesity: Defining the Silhouette of Disease Features in Overweight Patients

  • MS Diet & Nutrition
    /
  • MS Research Study and Reports
    /
  • Pediatric MS
    /
December  2023   Abstract Obesity has been suggested as an environmental risk factor for multiple sclerosis (MS) and may negatively…
MS Diet & Nutrition

December 13, 2023

Biologics and Biosimilars in Multiple Sclerosis

  • Boster's MS Corner
    /
  • MS Drug Therapies
    /
  In this video, Dr. Boster discusses the use of Biologics and Biosimilars in Multiple Sclerosis.  Visit the MS Views and…
Boster's MS Corner

December 13, 2023

What Is a Wash-Out Period? 8 Things To Know for DMTs (Disease Modifying Therapies)

  • Additional MS resource sites
    /
  • Misc. MS Related
    /
  • MS Drug Therapies
    /
 Written by Maureen McNulty Medically reviewed by Luc Jasmin, M.D., Ph.D., FRCS (C), FACS  If you have multiple sclerosis (MS) and want…
Additional MS resource sites

December 13, 2023

Vanda acquires rights to Ponvory for MS in US, Canada for $100M

  • MS Drug Therapies
    /
 by Patricia Inacio, PhD | December 12, 2023 Oral therapy approved in both countries to lower relapse rates Vanda Pharmaceuticals has acquired the U.S.…
MS Drug Therapies

December 13, 2023

“Inverse vaccine” shows potential to treat multiple sclerosis and other autoimmune diseases

  • MS Research Study and Reports
    /
 September 11, 2023 In a new study, Prof. Jeffrey Hubbell and fellow researchers describe a new “inverse vaccine” that in…
MS Research Study and Reports

December 6, 2023

Evobrutinib is no better than teriflunomide

  • MS Drug Therapies
    /
 The EVOLUTION phase 3 clinical trials showed evobrutinib did not meet its primary endpoint of annualized relapse rate for up…
MS Drug Therapies

November 23, 2023

Smoking during pregnancy and risk of multiple sclerosis in offspring and mother: A Danish nationwide register-based cohort study

  • MS Research Study and Reports
    /
                           (this photo is not directly associated with…
MS Research Study and Reports

November 21, 2023

Racial and Ethnic Disparities in Multiple Sclerosis MRI Outcomes

  • Clinical Trials
    /
  • Health Equity
    /
 Information provided by Sheila Thorne, President & CEO –  Multicultural Healthcare Marketing Group Specializing in Cultural Competency Training  Medically reviewed by…
Clinical Trials

November 20, 2023

CHAIR PILATES for the MS community

  • Marketing
    /
 For anybody wanting to catch up on some of #MSViewsandNews‘ previous #pilates classes, take a look at what you have…
Marketing

Categories

Latest Blog Posts